drugset / Trial / NCT02197156

A Multicenter Active Comparator Study of HC-ER in Adults Following Bunionectomy Surgery

NCT02197156

Phase 2 Completed 241 enrolled Zogenix, Inc.
RandomizedParallel-groupDouble-blindOther

Summary

The purpose of the study is to establish a dose-response relationship among several capsule strengths of Hydrocodone Bitartrate Extended Release (HC-ER) and to compare the efficacy to placebo following bunionectomy surgery

Timeline

Start
2002-08
Primary completion
2003-02
Completion
2003-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 325 mg
Comparator Hydrocodone Unknown 10 mg
Comparator Hydrocodone Unknown 20 mg
Comparator Hydrocodone Unknown 30 mg
Comparator Hydrocodone Unknown 40 mg

Indications

No indication recorded.